These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26804643)

  • 21. Insight into the structural requirements of thiophene-3-carbonitriles-based MurF inhibitors by 3D-QSAR, molecular docking and molecular dynamics study.
    Azam MA; Jupudi S
    J Recept Signal Transduct Res; 2017 Oct; 37(5):522-534. PubMed ID: 28768454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of Virtual Screening Methods in Prediction of PDE4B-inhibitor Activity.
    Shubina V; Niinivehmas S; Pentikainen OT
    Curr Drug Discov Technol; 2015; 12(2):117-26. PubMed ID: 26135856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
    Malla P; Kumar R; Kumar M
    Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discover natural compounds as potential phosphodiesterase-4B inhibitors via computational approaches.
    Li J; Zhou N; Liu W; Li J; Feng Y; Wang X; Wu C; Bao J
    J Biomol Struct Dyn; 2016 May; 34(5):1101-12. PubMed ID: 26159554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors.
    Lanka G; Begum D; Banerjee S; Adhikari N; P Y; Ghosh B
    Comput Biol Med; 2023 Nov; 166():107481. PubMed ID: 37741229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docking field-based QSAR and pharmacophore studies on the substituted pyrimidine derivatives targeting HIV-1 reverse transcriptase.
    Fan N; Zhang S; Sheng T; Zhao L; Liu Z; Liu J; Wang X
    Chem Biol Drug Des; 2018 Feb; 91(2):398-407. PubMed ID: 28816417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing.
    Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W
    J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly.
    Marimuthu P; Lee YJ; Kim B; Seo SS
    J Biomol Struct Dyn; 2019 Feb; 37(2):307-320. PubMed ID: 29322868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
    Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
    J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico studies on potential MCF-7 inhibitors: a combination of pharmacophore and 3D-QSAR modeling, virtual screening, molecular docking, and pharmacokinetic analysis.
    Badhani B; Kakkar R
    J Biomol Struct Dyn; 2017 Jul; 35(9):1950-1967. PubMed ID: 27401212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds.
    Xing M; Akowuah GA; Gautam V; Gaurav A
    J Biomol Struct Dyn; 2017 Oct; 35(13):2910-2924. PubMed ID: 27608741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of FIXa inhibitors by combination of pharmacophore modeling, molecular docking, and 3D-QSAR modeling.
    Li P; Peng J; Zhou Y; Li Y; Liu X; Wang L; Zuo Z
    J Recept Signal Transduct Res; 2018 Jun; 38(3):213-224. PubMed ID: 29724133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
    Chaudhari P; Bari S
    Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure-activity relationship (q-RASAR) and pharmacophore modeling.
    Khatun S; Dasgupta I; Islam R; Amin SA; Jha T; Dhaked DK; Gayen S
    Mol Divers; 2024 Aug; 28(4):2197-2215. PubMed ID: 38871969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.
    Lee YH; Yi GS
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Screening of CCR5 Inhibitors as Potential Entry Inhibitor Microbicides Using 3D-QSAR Studies, Docking and Molecular Dynamics Simulation.
    Ramachandran R; Aathi M; Ruban DD; Piramanyagam S
    Curr HIV Res; 2017; 15(4):234-244. PubMed ID: 28059045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR, molecular docking and molecular dynamics studies of a series of RORĪ³t inhibitors.
    Wang F; Yang W; Shi Y; Le G
    J Biomol Struct Dyn; 2015 Sep; 33(9):1929-40. PubMed ID: 25341687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches.
    Selvakumar R; Anantha Krishnan D; Ramakrishnan C; Velmurugan D; Gunasekaran K
    J Biomol Struct Dyn; 2020 Feb; 38(3):682-696. PubMed ID: 30806580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.